Immunotherapy: MULTI-TUMOR ASSOCIATED ANTIGEN SPECIFIC T CELL (TAA-T) THERAPY TO TREAT PEDIATRIC PATIENTS WITH HIGH-RISK CNS TUMORS: THE REMIND TRIAL

A. Geiger, R. Diccocio, M. Fortiz, M. Grant, H. Lang, A. Shibli,A. Datar, E. Reynolds,C. Lazarski, M. Jensen-Wachspress, G. Pezzella, D. Ayala-Gomez, J. Tanna, F. Hoq, P. Hanley, L. Kilburn, B. Rood, R. Packer, C. Cruz, E. Hwang

Cytotherapy（2023）

引用 0|浏览2